Board of Directors

Born in 1957

Member of the board of directors since the year 2005

Education

Master’s degree in Business Administration from the University of Aarhus in Denmark

Board positions

Nissens A/S (chairman)
KIRKBI A/S (deputy chairman)
The Thomas B. Thrige Foundation (chairman)
ABOUT YOU Holding GmbH (deputy chairman)

Directorships in several wholly and partly owned companies in the William Demant Group:
William Demant Holding A/S (deputy chairman)
Sennheiser Communications A/S (board member)
Vision RT Ltd. (chairman)
Founders A/S (chairman)
Boston Holding A/S (board member)
Jeudan A/S (chairman)
HIMPP A/S (chairman)

Experience

Mr. Jacobsen has broad management experience both as CEO and as chairman in major international companies, he is currently the CEO of William Demant Invest. Previous positions include CEO of William Demant Holding, President of Orion A/S and Vice President overseeing corporate affairs for both Atlas Danmark A/S and Thrige-Titan A/S.

Shares held in Össur

203,330 (incl. related parties). Mr. Jacobsen holds no share options in the Company

Other

Mr. Jacobsen has no interest links with the Company’s main clients or competitors.
Mr. Jacobsen is a dependent member of the Board

Born in 1943

Member of the board of directors since the year 1999

Education

Graduate of University of Iceland Medical School (1969)
Certified by the American Board of Physical Medicine and Rehabilitation (1976)

Experience

Chairman and Lucy Moses Professor of the Department of Rehabilitation Medicine at The Mount Sinai Medical Center in New York City (1986-2016). Has held numerous other leadership positions at Mount Sinai as well as in various American professional and cultural organizations. Dr. Ragnarsson current title is Emeritus Professor and Chairman of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai.

Shares held in Össur

Dr. Ragnarsson holds no shares nor share options in the Company.

Other

Dr. Ragnarsson has no interest links with the Company’s main clients, competitors, or major shareholders. Dr. Ragnarsson is a dependent member of the Board.

Born in 1968

Member of the board of directors since the year 2009

Education

Master’s degree in Business Administration from the Copenhagen Business School in Denmark

Board positions

Sennheiser Communications A/S (member)
Interacoustics A/S (president)

Experience

Mr. Nielsen has spent his entire career with William Demant Holding A/S in various and expanding roles throughout the world. After working as a management assistant to Mr. Niels Jacobsen and as an interim General Manager of Oticon Australia Pty Ltd. Mr. Nielsen assumed, in 1996, his current position as President of Diagnostic Instruments, which has operations worldwide.

Shares held in Össur

Mr. Nielsen neither has shares nor share options in the Company

Other

Mr. Nielsen has no interest links with the Company’s main clients or competitors. Mr. Nielsen is a dependent member of the Board.

Born in 1965

Member of the board of directors since the year 2008

Education

Doctorate in Industrial Relations from the London School of Economics

Experience

Dr. Grönfeldt is the senior advisor to the Dean at the Massachusetts Institute of Technology SA+P, a founding member of MIT’s newest innovation accelerator DesignX, and a co-founder of the MET fund, a Cambridge based seed investment fund. Previous positions include Chief Organizational Development Officer of Alvogen, an international generic pharmaceutical company, President of Reykjavik University, deputy to the CEO of Actavis Group, Assistant Professor of Economics and Business Administration at the University of Iceland and Managing Director and Managing Partner of IMG Gallup/ Deloitte.

Shares held in Össur

Dr. Grönfeldt holds no shares nor share options in the Company

Other

Dr. Grönfeldt has no interest links with the Company’s main clients, competitors, or major shareholders. Dr. Grönfeldt is an independent Board member.

Born in 1951

Member of the board of directors since the year 2013

Education

Master’s degree (Pharm.) from Copenhagen University

Board positions

Brunnur Investment Fund (chairman) Florealis ehf. (chairman)
Coripharma Holding ehf (chairman)
Orf Genetics hf. (member)
MentisCura ehf. (member)
Mentis Cura A/S (member)
Vistor hf. (member)
Heilsulausnir ehf. (member)
Saga Natura ehf. (member)
Pretium ehf. (Chairman)

Experience

Previous positions include President & EVP Strategic Projects of Actavis Plc in Iceland, a global integrated specialty pharmaceutical company; Deputy CEO and EVP Third Party Sales at Actavis Group hf.; Deputy CEO, Head of R&D, Assistant Managing Director, Development Manager, Regulatory Manager and Marketing Manager at Delta hf.; and Medical Representative at Pharmaco hf. She was the President of the European Generic Medicines Association (now Medicines for Europe) from 2011-2013..

Shares held in Össur

26,318 (incl. related parties). Ms. Eggertsdóttir holds no share options

Other

Ms. Eggertsdóttir has no interest links with the Company’s main clients or competitors. Ms. Eggertsdóttir is an independent member of the Board